To the Editor:
The inhibitor of kappa light polypeptide gene enhancer in b cells kinase gene (IKBKG), also known as NF-kappa B essential modulator (NEMO), is located on the X-chromosome and encodes the regulatory scaffold subunit of the inhibitor of kappa B kinase gamma (IKKγ) of the IKK complex. Upon activation, the IKK complex phosphorylates the inhibitor of kappa B (IKB), leading to its degradation and thereby facilitating nuclear translocation of NF-kappa B and transcription of genes involved in inflammation, immunity. and cell survival. Amorphic mutations in IKKγ producing a complete loss of functional protein cause incontinentia pigmenti (IP) in females, while they are embryonically lethal in most affected males [1] . On the other hand, hypomorphic IKBKG/NEMO mutations in males that impair but do not abolish NF-kappa B signaling lead to hypohidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) as well as immunodeficiency without EDA [2] . Multiple transcript variants encoding different isoforms of this gene have been identified [3] . A pseudogene encoding exons 3-10 is located in an adjacent region of the X-chromosome making diagnosis based on sequencing of genomic DNA (gDNA) challenging [4] . EDA-ID is inherited as an X-linked recessive disorder, although an autosomal dominant form, due to IKBA mutations, has been described [5] . Furthermore, IKBKB mutations cause an autosomal recessive immunodeficiency without signs of ectodermal dysplasia [6] .
We report a novel splice site mutation in IKBKG/NEMO leading to exon 9 skipping and a frameshift with premature termination identified in an infant with evidence of EDA and severe immunodeficiency. The patient was born at term to a G1P1 mother with a history of IP. He developed hypoglycemia and hypocalcemia with seizure-like activity shortly after birth. EEG was normal, and MRI demonstrated bilateral parietal findings consistent with small areas of ischemia but no structural defects. The infant was discharged home at 72 h of age. Ten days later, he developed poor feeding and body stiffening with eye deviation 6 h post-circumcision. Upon arrival to the ER, he was afebrile but ill appearing and was noted to have sparse hair, and absent eyelashes and eyebrows. The glans of his penis was erythematous following circumcision, but without swelling or discharge. He had edema of the scalp, hands, scrotum, and lower extremities and appeared sleepy with a poor suck. Initial CBC demonstrated Hb 16.2 g/dL, WBC 6100/mm 3 (ANC 1800/mm 3 , ALC 3100/mm 3 ), and platelets 66,000/ mm 3 . C-reactive protein (CRP) was 1.6 mg/dL. Chest radiograph revealed multifocal infiltrates consistent with pneumonia. Blood, urine, and CSF cultures grew methicillin susceptible Staphylococcus aureus (MSSA). Echocardiography on hospital day 4 revealed a 1-cm mobile, pedunculated mass on the wall of the left ventricle. Repeat MRI of the brain demonstrated reduced diffusivity consistent with microinfarcts, porencephaly, periventricular white matter changes, multiple microabscesses, leptomeningeal and cranial nerve enhancement, and absent frontal incisors. Over The patient's mother had stigmata consistent with IP manifested by missing incisors and a small hyperpigmented lesion on her abdomen. Three maternal sisters and grandmother also had cutaneous and dental manifestations of IP, and their diagnoses were previously made clinically so genetic testing of IKBKG/NEMO was pursued. Coding exons and adjacent splicing sites of the patient's gDNA (from whole blood) were Sanger sequenced, and a donor splice site variant (IKBKG c. 1117+5G>C) was identified ( Supplementary Fig. 1e) . MutationTaster predicted the loss of the exon 9 splice acceptor leading to IKBKG exon skipping with a frameshift and a premature termination codon. The patient's complementary DNA (cDNA) (from peripheral blood mononuclear cells (PBMCs)) yielded only mutant message revealing the predicted IKBKG exon 9 skipping and frameshift/premature termination ( Supplementary Fig. 1e ). Maternal gDNA (from whole blood) and cDNA (from PBMCs) were examined and demonstrated the same donor splice site variant on gDNA but only wild type allele on cDNA, suggesting nonrandom maternal Xchromosome inactivation. Maternal cDNA was analyzed by cloning and sequencing that revealed only the expression of the wild type allele (Fig. 1a) . PCR-based human androgen receptor (HUMARA) gene assay showed a 3 bp difference in the maternal X-chromosomes but only a single allele was amplified following HpaII digestion supporting nonrandom X-chromosome inactivation (Supplementary Fig. 2e) .
While the mother's PBMCs expressed only wild type protein, western blot data from patient PBMCs showed reduced sized mutant NEMO protein consistent with the cDNA sequencing that predicted exon 9 skipping and frameshift (R352SfsX22) resulting in a premature termination of the Cterminal region (Fig. 1a) .
To test NF-kappa B function, proliferation to PHA and cytokine production to toll-like receptor (TLR) ligands by PBMCs were measured. The patient's PBMCs demonstrated diminished proliferation compared with mother and controls; however, addition of exogenous IL-2 normalized the patient's proliferative response (Fig. 1b) . This finding was consistent with failure of the patient's T cells to produce IL-2 in response to CD3/CD28 stimulation (Fig. 1b) . The patient's production of TLR-induced IL-6 and TNF-α were also markedly impaired compared with mother and controls (Fig. 1b) . This patient's mutation has not previously been reported and is not present in the LOVD database. Orange et al.
reported a patient with an acceptor splice site mutation described to produce IKBKG exon 9 skipping [7] . In contrast to our patient, their patient demonstrated both mutant and WT message and protein, varying at different study time points, suggesting that the splice site mutation was permissive for residual production of a wild type transcript.
Our patient's failure to express wild type IKKγ is consistent with severe immunodeficiency evidenced by overwhelming MSSA sepsis in the first 2 weeks of life. These findings contrast with the milder clinical presentation of the patient reported by Orange et al. The immunologic findings in their patient suggested a moderate level of immune dysfunction manifesting as reduced specific antibody production, reduced NF-kappa B p65 nuclear translocation, and variable TLRinduced TNF production. The relatively low CRP in the face of overwhelming bacterial infection is likely the product of markedly decreased TLR response to multiple agonists with virtual absence of IL-6 production. The clear distinction between these patients both of whom had exon 9 splicing defects is the absence versus presence of wild type IKKγ. This suggests that IKKγ lacking the product of exon 9 and the zinc finger domain may be sufficient for embryogenesis but insufficient for normal ectodermal development and immunity.
